Jaguar Health Inc Stock Nasdaq
Equities
US47010C2017
Biotechnology & Medical Research
Sales 2024 * | 15.11M 20.75M | Sales 2025 * | 22.66M 31.12M | Capitalization | 21.4M 29.39M |
---|---|---|---|---|---|
Net income 2024 * | -26M -35.71M | Net income 2025 * | -21M -28.84M | EV / Sales 2024 * | 1.42 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.94 x |
P/E ratio 2024 * |
-0.75
x | P/E ratio 2025 * |
-0.96
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.25% |
Latest transcript on Jaguar Health Inc
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 19-04-30 |
Chief Tech/Sci/R&D Officer | 60 | 17-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
James Bochnowski
CHM | Chairman | 80 | 14-01-31 |
John Micek
BRD | Director/Board Member | 71 | 16-03-31 |
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |